PI Publications
- 2020Clinicoepidemiological profile and outcome predicted by minimal residual disease in children with mixed-phenotype acute leukemia treated on a modified MCP-841 protocol at a tertiary cancer institute in India. J Pediatr Hematol Oncol. 2020. PMID: 32604336
Myint H, Tondon S, Narula G, Prasad M , Subramaniam P, Patkar N, Tembhare P, Gujral S, Banavali S
Sequential treatment of arsenic trioxide followed by all trans retinoic acid with anthracyclines has excellent long-term cure in acute promyelocytic leukemia. Indian J Hematol Blood Transf.2020.Devdas SK, Jain H, Bagal B, Sengar M, Dangi U, Khattry N, Ambre P, Patkar N, Subramaniam PG, Nair R, Menon H
Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy. Med Oncol. 37(5): 48, 2020. PMID: 32277283Bagal B, Kumar R, Gaur T, Talreja V, Bonda A, Patkar N, Shetty D, Kowtal P, Subramanian PG, Gupta S, Sarin R, Hasan SK
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: An implication for anti-CD38 immunotherapy. J Immunother Cancer. 8:e000630, 2020. PMID: 32439800Tembhare P, Sriram H, Khanka T, Chatterjee G, Panda D, Ghogale S, Badrinath Y, Deshpande N, Patkar N, Narula G, Bagal B, Jain H, Sengar M, Khattry N, Banavali S, Gujral S, Subramanian PG
Post-induction measurable residual disease using multicolor flow cytometry is strongly predictive of inferior clinical outcome in the real-life management of childhood T-cell acute lymphoblastic leukemia: A study of 256 patients. Front Oncol. 10:577, 2020. PMID: 32391267Tembhare P, Narula G, Khanka T, Ghogale S, Chatterjee G, Patkar N, Prasad M, Badrinath Y, Deshpande N, Gudapati P, Verma S, Sanyal M, Kunjachan F, Mangang G, Gujral S, Banavali S, Subramanian P
Cytogenetic profile and outcome of a pediatric acute promyelocytic leukemia patient presenting with isolated isochromosome 17q in absence of RARA rearrangement. Blood Cells Mol Dis. 2020.PMID: 32414556Jain H, Shetty D, Narula G, Roy Moulik N, Tembhare P, Patkar N, Subramanian PG, Banavali S
NARASIMHA: Novel assay based on targeted RNA sequencing to identify ChiMeric gene fusions in hematological malignancies. Blood Cancer J. 10(5): 50, 2020. PMID: 32372024Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G, Tembhare P, Dhamne C, Prasad M, Moulik NR, Shetty D, Gokarn A, Bonda A, Nayak L, Punatkar S, Bagal B, Sengar M, Narula G, Khattry N, Banavali S, Subramanian PG, Gujral S
Clinical, hematological and cytogenetic profile in fibroblast growth factor receptor 1 rearranged hematoloymphoid malignancies. Int J Res Med Sci. 8 (4): 1556-1563, 2020Shetty D, Talker E, Mohanty P, Jain H, Yadav AK, Jain H, Nayak L, Tembare P, Patkar N, Subramanian PG, Kumar A
A High-sensitivity 10-color flow cytometric minimal residual disease assay in B-Lymphoblastic leukemia/lymphoma can easily achieve the sensitivity of 2-in- 106 and is superior to standard minimal residual disease assay: A study of 622 Patients. Cytometry B Clin Cytom. 98(1): 57-67, 2020. PMID: 31197916Tembhare PR, Subramanian PG, Ghogale S, Chatterjee G, Patkar NV, Gupta A, Shukla R, Badrinath Y, Deshpande N, Narula G, Rodrigues P, Girase K, Dhaliwal D, Prasad M, Shetty D, Banavali S, Gujral S
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2. Heliyon. 6(7):e04405, 2020. PMID: 32665985Dharavath B, Yadav N, Desai S, Sunder R, Mishra R, Ketkar M, Bhanshe P, Gupta A, Redhu AK, Patkar N Dutt S, Gupta S, Dutt A
- 2019A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1. Blood Cancer J. 9(10): 79, 2019. PMID: 31575857
Patkar N, Shaikh AF, Kakirde C, Nathany S, Ramesh H, Bhanshe P, Joshi S, Chaudhary S, Kannan S, Khizer SH, Chatterjee G, Tembhare P, Shetty D, Gokarn A, Punatkar S, Bonda A, Nayak L, Jain H, Khattry N, Bagal B, Sengar M, Gujral S, Subramanian P
Utility of immunophenotypic measurable residual disease in adult acute myeloid leukemia –Real world context. Front. Oncol. 2019.Patkar N, Kakirde C, Bhanshe P, Joshi S, Chaudhary S, Yajamanam B, Ghogale S, Deshpande N, Tembhare P, Kadechkar S, Kannan S, Shetty D, Gokarn A, Punatar S, Bonda A, Nayak L, Jain H, Bagal B, Menon H, Sengar M, Hasan KS, Khattry N, Gujral S, Subramanian P
- 2018Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia. Oncotarget. 9(93): 36613-36624, 2018. PMID: 30564301
Patkar N, Kodgule R, Kakirde C, Raval G, Bhanshe P, Joshi S, Chaudhary S, Badrinath Y, Ghoghale S, Kadechkar S, Khizer SH, Kannan S, Shetty D, Gokarn A, Punatkar S, Jain H, Bagal B, Menon H, Sengar M, Khattry N, Tembhare P, Subramanian P, Gujral S
Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD assay. Cytometry B Clin Cytom. 94(1):100-111, 2018.PMID: 27718302Tembhare PR, Ghogale S, Ghatwai N, Badrinath Y, Kunder N, Patkar NV, Bibi AR, Chatterjee G, Arora B, Narula G, Banawali S, Deshpande N, Amare P, Gujral S, Subramanian PG
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India. Indian J Pathol Microbiol. 61(2): 209-213, 2018. PMID: 29676359Rabade N, Subramanian PG, Kodgule R, Raval G, Joshi S, Chaudhary S, Mascarenhas R, Tembhare P, Gujral S, Patkar N
Molecular heterogeneity in actute promyelocytic leukemia - A single centre experience form India. Mediterr J Hematol Infect Dis. 10: e2018002, 2018.Rabade N, Raval G, Chaudhary S, Subramanian PG, Koduge R, Joshi S, Tembhare P, Hasan Sk, Jain H, Sengar M, Narula G, Banavali S, Amare Kadam P, Shetty D, Gujral S, Patkar N
Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit. Indian J Cancer. 55: 9-15, 2018. PMID: 30147087Khattry N, Laskar S, Sengar M, Rangarajan V, Shet T, Subramanian P G, Epari S, Bagal B, Goda JS, Agarwal A, Jain H, Tembhare P, Patkar N, Khanna N, Punatar S, Gokarn A, Shetty D, Jain H, Bonda A, Gota V, Hasan S, Kode J, Dutt S, Kulkarni S, Shetty N, Sable N, Deodhar J, Jadhav S, Pawaskar P, Mathew l, Menon H, Nair R, Kannan S, Chiplunkar SV, Gujral S
BRAFV600E mutation in hairy cell leukemia: A single-center experience. Indian J Pathol Microbiol. 61: 532-6, 2018. PMID: 30303143Bibi A, Java S, Chaudhary S, Joshi S, Mascerhenas R, Rabade N, Tembhare P, Subramanian PG, Gujral S, Menon H, Khattry N, Sengar M, Bagal B, Jain H, Patkar N
- 2017Immunogenetics of chronic lymphocytic leukemia. Indian J Pathol Microbiol. 60(1): 38-42, 2017. PMID: 28195089
Patkar N, Rabade N, Kadam PA, Mishra F, Muranjan A, Tembhare P, Chaudhary S, Joshi S, Jain H, Dangi U, Bagal B, Khattry N, Menon H, Gujral S, Sengar M, Subramanian PG
A rare extramedullary and extralymphoid presentation of mixed phenotypic blastic hematolymphoid neoplasm: A study of two cases. Indian J Med Paediatr Oncol. 38(3): 394-397, 2017. PMID: 29200701Ghodke K, Tembhare P, Patkar N, Subramanian PG, Arora B, Gujral S
CD19 Negative precursor B acute lymphoblastic leukemia (B-ALL) - immunophenotypic challenges in diagnosis and monitoring: A study of three cases. Cytometry B Clin Cytom. 92B(4):315-318, 2017. PMID: 27018867Ghodke K, Bibi A, Rabade N, Patkar N, Subramanian PG, Aamre Kadam P, Badrinath Y, Ghogale S, Gujral S, Tembhare P
Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature. Indian J Pathol Microbiol. 60(1): 84-86, 2017. PMID: 28195098Ghodke KA, Patkar NV, Subramanian PG, Gujral S, Kadam PA, Tembhare PR
- 2016Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: Not just missense mutations but insertions and deletions are also associated with TKI resistance. Leuk Lymphoma. 57(11): 2653-60, 2016. PMID: 26999421
Patkar N, Ghodke K, Joshi S, Chaudhary S, Mascerhenas R, Dusseja S, Mahadik S, Gaware S, Tembhare P, Gujral S, Kabre S, Kadam-Amare P, Jain H, Dangi U, Bagal B, Khattry N, Sengar M, Arora B, Narula G, Banavali S, Menon H, Subramanian PG
Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes. Int J Lab Hematol. 38(6): e102-e106, 2016. PMID: 27461906Patkar N, Joshi S, Chaudhary S, Mascerhenas R, Doshi H, Tembhare P, Gujral S, Subramanian PG
A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping. Cytometry A.89(3): 281-91, 2016. PMID: 26671309Tembhare P, Badrinath Y, Ghogale S, Patkar N, Dhole N, Dalavi P, Kunder N, Kumar A, Gujral S, Subramanian PG
- 2015MYD88 Mutant Lymphoplasmacytic Lymphoma / Waldenstroms Macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart. Leuk Lymphoma.56(2): 420-425,2015. PMID: 24828863
Patkar N, Subramanian PG, Deshpande P,Ghodke K, Tembhare, P, Mascarenhas R, Muranjan A, Chaudhary S, Bagal B, Gujral S, Sengar M, Menon H